Financials

News Ideas Minds Forecast

SMZ1 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Sino Biopharmaceutical Ltd.

Total assets of SMZ1 for H2 23 is 8.12 B EUR, 1.92% less than the previous H1 23. And total liabilities decreased by 12.10% in H2 23 to 3.18 B EUR.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—